Saroglitazar Magnesium
Saroglitazar Magnesium is a dual PPARα/γ agonist, exhibiting potent PPARα activation (EC50 0.65 pM) and moderate PPARγ activation (EC50 3 nM) . This investigational compound is utilized in preclinical research for studying metabolic disorders, including dyslipidemia and fatty liver disease, in both cellular and animal models.
Product Specifications
CAS Number
1639792-20-3
Product Name Alternative
PPARγ, PPARα, Saroglitazar Magnesium
Field of Research
Metabolism Research, Molecular Biology, Pharmacology & Drug Discovery
Purity
98.10% (May vary between batches)
Solubility
DMSO:112.5 mg/mL (124.8 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (4.44 mM)
Smiles
C (C) O1[Mg+2]2 (O (CC) C (CC3=CC=C (OCCN4C (=CC=C4C) C5=CC=C (SC) C=C5) C=C3) C (=O) [O-]2) [O-]C (=O) C1CC6=CC=C (OCCN7C (=CC=C7C) C8=CC=C (SC) C=C8) C=C6
Molecular Formula
C50H56MgN2O8S2
Molecular Weight
901.43
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
